Paper64803
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
Marshall AJ and 3 others. Lancet, 1977. Cited by 56 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. Papers, record 64803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/64803
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bendroflumethiazide | Major topic |
| Hypertension | Major topic |
| Prazosin | Major topic |
| Quinazolines | Major topic |
| Adult | |
| Aged | |
| Atenolol | |
| Blood Pressure | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Female | |
| Heart Rate | |
| Humans | |
| Male | |
| Middle Aged | |
| Oxprenolol | |
| Propranolol |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30,221,227 | Phosphatase CDC25B Inhibitors Produced by Basic Alumina-Supported One-Pot Gram-Scale Synthesis of Fluorinated 2-Alkylthio-4-aminoquinazolines Using Microwave Irradiation. | ACS Omega | 2018 | https://conductscience.org/library/papers/30221227 | PubMed |
| 7,437,237 | Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7437237 | PubMed |
| 7,388,366 | Hypokalaemia and diuretics: an analysis of publications. | Br Med J | 1980 | https://conductscience.org/library/papers/7388366 | PubMed |
| 7,295,482 | Assessment of natriuretic drugs. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7295482 | PubMed |
| 7,093,116 | Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093116 | PubMed |
| 7,066,169 | The addition of prazosin to standard triple therapy in the treatment of severe hypertension. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7066169 | PubMed |
| 6,992,462 | Antihypertensive pharmacology. | West J Med | 1980 | https://conductscience.org/library/papers/6992462 | PubMed |
| 6,487,502 | Xipamide: no advantage over bendrofluazide in hypertension. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6487502 | PubMed |
| 6,357,257 | Hydralazine and prazosin in the treatment of hypertension. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6357257 | PubMed |
| 6,122,737 | What should we do about mild hypertension? | J R Coll Physicians Lond | 1982 | https://conductscience.org/library/papers/6122737 | PubMed |
| 6,122,463 | Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6122463 | PubMed |
| 6,109,022 | Diuretic and beta-blocker in hypertension--then what? | J R Coll Physicians Lond | 1980 | https://conductscience.org/library/papers/6109022 | PubMed |
| 3,899,671 | A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3899671 | PubMed |
| 702,462 | Altitude sickness. | J R Coll Gen Pract | 1978 | https://conductscience.org/library/papers/702462 | PubMed |
| 630,494 | Prazosin hydrochloride. | Can Med Assoc J | 1978 | https://conductscience.org/library/papers/630494 | PubMed |
| 143,363 | Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension. | Drugs | 1977 | https://conductscience.org/library/papers/143363 | PubMed |
| 38,096 | Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension. | Drugs | 1979 | https://conductscience.org/library/papers/38096 | PubMed |
| 26,370 | The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/26370 | PubMed |
| 23,284 | Antihypertensive drugs: clinical pharmacology and therapeutic use. | Drugs | 1977 | https://conductscience.org/library/papers/23284 | PubMed |
| 20,118 | Treating hypertension. The place of beta blockade. | Br Heart J | 1977 | https://conductscience.org/library/papers/20118 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/64803
GET https://conductscience.org/api/papers/v1/64803/authors